期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 92, 期 4, 页码 434-436出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2012.130
关键词
-
资金
- Pfizer
In a 2010 review in Clinical Pharmacology & Therapeutics, Nick Holford noted that in neonates and young infants, maturation of the organs responsible for drug clearance is a more important determinant of pharmacokinetics (PK) than is body size.(1) Here we review recent developments that provide new insights into how physiological and environmental changes associated with adaptation to extrauterine life affect the ontogeny of drug biotransformation and interpretation of genotype-phenotype relationships in newborns and infants.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据